Annals
Established in 1927 by the American College of Physicians
:
Advanced search
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article
space
 arrow  PDF of this article
(PDFs free after 6 months)
space
 arrow  Summary for Patients
space
 arrow  Summary for Patients (PDF)
space
 arrow  Figures/Tables List
space
 arrow  Related articles in Annals
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box Social Bookmarking
 Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter
What's this?
box PubMed
Articles in PubMed by Author:
 arrow  Nunnari, G.
space
 arrow  Cacopardo, B.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

BRIEF COMMUNICATION

Slower Progression of HIV-1 Infection in Persons with GB Virus C Co-Infection Correlates with an Intact T-Helper 1 Cytokine Profile

right arrow Giuseppe Nunnari, MD; Luciano Nigro, MD; Filippo Palermo, ScD; Massimo Attanasio, PhD; Annemarie Berger, MD; Hans W. Doerr, MD; Roger J. Pomerantz, MD; and Bruno Cacopardo, MD

1 July 2003 | Volume 139 Issue 1 | Pages 26-30

Background: Progression to AIDS is slower in persons infected with both HIV-1 and GB virus C (GBV-C), also known as hepatitis G virus.

Objective: To compare clinical, virologic, and immunologic variables in HIV-1–seropositive patients with and without GBV-C co-infection.

Design: Subanalysis of a prospective cohort study.

Setting: Institute of Infectious Diseases, University of Catania, Catania, Italy.

Patients: 80 asymptomatic HIV-1–seropositive patients.

Measurements: GBV-C RNA level; plasma HIV-1 viral load; CD4+ cell counts; and serum levels of interleukin (IL)-2, IL-4, IL-10, and IL-12.

Results: At the start of the study, plasma GBV-C RNA was detected in 17 patients (21%). During follow-up, IL-2 and IL-12 levels decreased significantly (P = 0.005 and P = 0.01, respectively) and IL-4 and IL-10 levels increased significantly (P = 0.01 and P = 0.004, respectively) in the GBV-C–negative group but did not change substantially in the GBV-C–positive group. Each measured variable differed significantly between GBV-C–positive and GBV-C–negative groups during follow-up (P < 0.001 for IL-12, IL-4, and IL-10; P = 0.002 for IL-2).

Conclusion: GB virus C may immunologically interfere with progression of HIV-1 infection to AIDS by maintaining an intact T-helper 1 cytokine profile.


Editors' Notes
space

Context

  • Patients infected with HIV-1 progress to AIDS more slowly if they are co-infected with hepatitis G virus, also called GB virus C (GBV-C), than if they are not. The mechanism of this effect of GBV-C infection is not known.

Contribution

  • Among 80 asymptomatic HIV-1–infected patients, T-helper 1 cytokine profiles changed unfavorably in those without GBV-C infection and remained stable in those with GBV-C infection.

Implications

  • Co-infection with GBV-C may slow progression of HIV-1 infection through a mechanism related to T-helper 1 cytokines.

–The Editors

 

Author and Article Information
space

From University of Catania, Catania, Italy; Thomas Jefferson University, Philadelphia, Pennsylvania; University of Palermo, Palermo, Italy; and Johann Wolfgang Goethe University, Frankfurt/Main, Germany.

Acknowledgments: The authors thank the patients from the University of Catania clinics. They also thank Brenda O. Gordon and Rita Victor at the Center for Human Virology and Biodefense, Thomas Jefferson University, for excellent secretarial assistance and Drs. Carlo Vancheri and Valerio Tomaselli from the Chest Disease Unit of the Department of Internal Medicine and Medical Specialties at the University of Catania for providing some of the laboratory reagents.

Grant Support: By academic funds from the Institute of Infectious Diseases, University of Catania; the Center for Human Virology and Biodefense, Thomas Jefferson University; and the Institute of Medical Virology, Johann Wolfgang Goethe University.

Potential Financial Conflicts of Interest: None disclosed.

Requests for Single Reprints: Giuseppe Nunnari, MD, Jefferson Alumni Hall, Thomas Jefferson University, 1020 Locust Street, Suite 329, Philadelphia, PA 19107; e-mail, gnunnari{at}hotmail.com.

Current Author Addresses: Drs. Nunnari and Pomerantz: Jefferson Alumni Hall, Thomas Jefferson University, 1020 Locust Street, Suite 329, Philadelphia, PA 19107.

Drs. Nigro, Palermo, and Cacopardo: Unit of Infectious Diseases, University of Catania, Via Passo Gravina 185, 95125 Catania, Italy.

Drs. Berger and Doerr: Institute fur Medizinische Virologie, Paul-Ehrlich Strasse 40, 60596 Frankfurt, Germany.

Dr. Attanasio: Dipartimento dei Metodi Quantitativi per le Scienze Umane, University of Palermo, Viale delle Scienze, 90128 Palermo, Italy.

Author Contributions: Conception and design: G. Nunnari, L. Nigro, H.W. Doerr, R.J. Pomerantz, B. Cacopardo.

Analysis and interpretation of the data: G. Nunnari, L Nigro, F. Palermo, R.J. Pomerantz, B. Cacopardo.

Drafting of the article: G. Nunnari, R.J. Pomerantz, B. Cacopardo.

Critical revision of the article for important intellectual content: G. Nunnari, R.J. Pomerantz, B. Cacopardo.

Final approval of the article: G. Nunnari, R.J. Pomerantz, B. Cacopardo.

Statistical expertise: F. Palermo, M. Attanasio.

Obtaining of funding: B. Cacopardo.

Administrative, technical, or logistic support: A. Berger, H.W. Doerr.

Collection and assembly of data: G. Nunnari, L. Nigro, F. Palermo, A. Berger, H.W. Doerr, B. Cacopardo.

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related articles in Annals:

Summaries for Patients
Hepatitis G Virus Co-Infection Slows Progression from HIV Infection to AIDS: The Potential Role of Cytokines
Annals 2003 139: I-65. [Full Text]  



This article has been cited by other articles:


Home page
J. Clin. Microbiol.Home page
J. T. Stapleton, C. F. Williams, and J. Xiang
GB Virus Type C: a Beneficial Infection?
J. Clin. Microbiol., September 1, 2004; 42(9): 3915 - 3919.
[Full Text] [PDF]


Home page
NEJMHome page
P. Bjorkman, L. Flamholc, A. Widell, F. Canducci, A. Lazzarin, M. Clementi, J. T. Stapleton, C. F. Williams, and J. Xiang
GB Virus C and Survival in Persons with HIV Infection
N. Engl. J. Med., June 17, 2004; 350(25): 2617 - 2618.
[Full Text] [PDF]




 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 2003 by the American College of Physicians.